Age specific differences in efficacy and safety for the CYD-tetravalent dengue vaccine.
about
A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesisHabitat productivity and pyrethroid susceptibility status of Aedes aegypti mosquitoes in Dar es Salaam, Tanzania.Characteristics of and factors associated with dengue vector breeding sites in the City of Colombo, Sri Lanka.Dengue serotype immune-interactions and their consequences for vaccine impact predictionsPotent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine.Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine.The additional benefit of residual spraying and insecticide-treated curtains for dengue control over current best practice in Cuba: Evaluation of disease incidence in a cluster randomized trial in a low burden setting with intensive routine control.
P2860
Q28804076-7053D479-8792-4898-A06F-CE85C1085076Q33781708-D5F8857A-0C27-4AE0-8E09-FF4B4EA75F02Q36972218-6016C4A7-FDCC-4A9B-9B2C-DBF6A5820ADEQ37270826-524F2111-60A6-4C06-B9AA-F3C6DC356773Q40040450-215CDDBD-F073-421F-9639-0F2EF805E2BDQ40093852-49781BF9-47A7-4531-9AB4-20C444BBF5F6Q43046632-6DD4F83E-3FE0-4F35-850D-5F6C9EC6DE65
P2860
Age specific differences in efficacy and safety for the CYD-tetravalent dengue vaccine.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Age specific differences in efficacy and safety for the CYD-tetravalent dengue vaccine.
@en
type
label
Age specific differences in efficacy and safety for the CYD-tetravalent dengue vaccine.
@en
prefLabel
Age specific differences in efficacy and safety for the CYD-tetravalent dengue vaccine.
@en
P2860
P1476
Age specific differences in efficacy and safety for the CYD-tetravalent dengue vaccine.
@en
P2093
Eduardo Massad
P2860
P304
P356
10.1586/14760584.2016.1143366
P577
2016-01-17T00:00:00Z